Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline glioma.
Ontology highlight
ABSTRACT: Therapeutic resistance remains a major obstacle to preventing progression of H3K27M-altered Diffuse Midline Glioma (DMG). Resistance is driven in part by ALDH-positive cancer stem cells (CSC), with high ALDH1A3 expression observed in H3K27M-mutant DMG biopsies. We hypothesized that ALDH-mediated stemness and resistance may in part be driven by the oncohistone itself. Upon deletion of H3K27M, ALDH1A3 expression decreased dramatically and was accompanied by a gain in astrocytic marker expression and a loss of neurosphere forming potential, indicative of differentiation. Here we show that the oncohistone regulates histone acetylation through ALDH1A3 in a Wnt-dependent manner and that loss of H3K27M expression results in sensitization of DMGs to radiotherapy. The observed elevated Wnt signalin
SUBMITTER: Sharma M
PROVIDER: S-EPMC10474232 | biostudies-literature | 2023 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA